Graham Capital Management »

Miragen Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $328k 14k 22.75
2024-06-30 $292k 22k 13.01

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics